the effects of intravenous injections of the opiate antagonist naloxone ( 0.005-0.4 mg/kg body weight ) on respiratory pattern , apnoea duration and frequency were investigated in six infants with severe sleep apnoea syndrome .
C0003578
apnoea
C0037315
sleep apnoea syndrome